Literature DB >> 4107395

Prevention of urinary-tract infection with low-dose nitrofurantoin.

R R Bailey, A P Roberts, P E Gower, H E De Wardener.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4107395     DOI: 10.1016/s0140-6736(71)91270-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Guidelines for the diagnosis and management of recurrent urinary tract infection in women.

Authors:  Shawn Dason; Jeyapandy T Dason; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

2.  Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.

Authors:  A R Ronald; C K Harding; R Mathias; C K Wong; P Muir
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

3.  Adverse drug reactions during treatment of urinary tract infections.

Authors:  L E Böttiger; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953

4.  Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women.

Authors:  L E Nicolle; G K Harding; M Thompson; J Kennedy; B Urias; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

Review 5.  Urinary tract infection: some recent concepts.

Authors:  R R Bailey
Journal:  Can Med Assoc J       Date:  1972-08-19       Impact factor: 8.262

6.  Recurrent urinary infections in a girl.

Authors:  R H Jackson; A Smith
Journal:  Br Med J       Date:  1972-05-27

7.  Recurrent urinary infections in a girl.

Authors:  R R Bailey
Journal:  Br Med J       Date:  1972-04-22

Review 8.  Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.

Authors:  X Albert; I Huertas; I I Pereiró; J Sanfélix; V Gosalbes; C Perrota
Journal:  Cochrane Database Syst Rev       Date:  2004

9.  Bacteria causing symptomatic urinary tract infection or asymptomatic bacteriuria.

Authors:  A P Roberts; R Phillips
Journal:  J Clin Pathol       Date:  1979-05       Impact factor: 3.411

10.  Comparative in vitro activity of norfloxacin against urinary tract pathogens.

Authors:  D Haase; B Urias; G Harding; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.